Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case–control study

References

• Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, A new model for an etiology of rheumatoid arthritis. Arthritis Rheum 2006;54:38–46.
   PubMed Web of Science ®Google Scholar
• Rantapaa Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741–9.
   PubMedGoogle Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917–23.
   PubMed Web of Science ®Google Scholar
• Johansson M, Arlestig L, Hallmans G, Rantapaa-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther 2006;8:R19.
   PubMed Web of Science ®Google Scholar
• Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994;37:808–13.
   PubMed Web of Science ®Google Scholar
• Karlsson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Arthritis Rheum 2004;3458–67.
   PubMedGoogle Scholar
• Pikwer M, Bergstrom U, Nilsson J-Aa, Jacobsson L, Berglund G, Turesson C. Breastfeeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009;68:526–30.
   PubMed Web of Science ®Google Scholar
• Jorgensen C, Picot MC, Bologna C, Sany J. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 1996;55:94–8.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Valkenburg HA, Boersma JW, Cats A, Festen JJ, Huber-Bruning O, Oral contraceptives and rheumatoid arthritis: further evidence for a protective effect. Lancet 1982;2:839–42.
   PubMed Web of Science ®Google Scholar
• Allebeck P, Ahlbom A, Ljungstrom K, Allander E. Do oral contraceptives reduce the incidence of rheumatoid arthritis? A pilot study using the Stockholm County medical information system. Scand J Rheumatol 1984;13:140–6.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Witteman JC, Valkenburg HA, Boersma JW, Cats A, Festen JJ, Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. J Am Med Assoc 1986;255:1299–303.
   PubMed Web of Science ®Google Scholar
• Spector TD, Roman E, Silman AJ. The pill, parity, and rheumatoid arthritis. Arthritis Rheum 1990;33:782–9.
   PubMedGoogle Scholar
• Brennan P, Bankhead C, Silman A, Symmons D. Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 1997;26:817–23.
   PubMed Web of Science ®Google Scholar
• Doran MF, Crowson CS, O’Fallon WM, Gabriel SE. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 2004;31:207–13.
   PubMed Web of Science ®Google Scholar
• Uhlig T, Hagen K, Kvien T. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol 1999;26:47–54.
   PubMed Web of Science ®Google Scholar
• Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999;42:910–17.
   PubMed Web of Science ®Google Scholar
• Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62:835–41.
   PubMed Web of Science ®Google Scholar
• Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006;119:503–11.
   PubMed Web of Science ®Google Scholar
• Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S. Occupation, occupational exposure to chemicals and rheumatological disease. Scand J Rheumatol 1994;23:305–10.
   PubMed Web of Science ®Google Scholar
• Reckner Olsson Aa, Skogh T, Wingren G. Occupational determinants for rheumatoid arthritis. Scand J Work Environ Health 2000;26:243–9.
   PubMedGoogle Scholar
• Klockars M, Koskela RS, Jarvinen E, Kolari PJ, Rossi A. Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940–81. Br J Med J (Clin Res Ed) 1987;294:997–1000.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Olerup O, Zetterqvist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serologic DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225–35.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953–62.
   PubMed Web of Science ®Google Scholar
• Einarsdottir E, Egerbladh I, Beckman L, Holmberg D, Escher SA. The genetic population of northern Sweden and its implications for mapping genetic diseases. Hereditas 2007;144: 171–80.
   PubMedGoogle Scholar
• Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007;6:537–42.
   PubMed Web of Science ®Google Scholar
• Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naïve B cell repertoire. J Clin Invest 2003:111:275–83.
   PubMed Web of Science ®Google Scholar
• Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005;101:123–43.
   PubMed Web of Science ®Google Scholar
• Athreya BH, Pletcher J, Zulian F, Weiner DB, Williams WV. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clin Immunol Immunopathol 1993;66:201–11.
   PubMedGoogle Scholar
• Matera L, Mori M, Galetto A. Effect of prolactin on antigen presenting function of monocyte derived dendritic cells. Lupus 2001;10:728–34.
   PubMed Web of Science ®Google Scholar
• Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 1996;348:106–9.
   PubMed Web of Science ®Google Scholar
• Lee YC, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L, The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthritis Rheum 2009;60:1250–4.
   PubMedGoogle Scholar
• Ram S, Blumberg D, Newton P, Anderson NR, Gama R. Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact? Rheumatology 2004;43:1272–4.
   PubMedGoogle Scholar
• Linos A, Worthington JW, O’Fallon WM, Kurland LT. Case-control study of rheumatoid arthritis and prior use of oral contraceptives. Lancet 1983;1:1299–300.
   PubMed Web of Science ®Google Scholar
• del Junco DJ, Annegers JF, Luthra HS, Coulam CB, Kurland LT. Do oral contraceptives prevent rheumatoid arthritis? J Am Med Assoc 1985;254:1938–41.
   PubMed Web of Science ®Google Scholar
• Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against citrullinated peptides. Arthritis Res Ther 2006;8:R133.
   PubMed Web of Science ®Google Scholar